Skip to main content
ZENA
NASDAQ Technology

CEO Dr. Shaun Passley Consolidates 86.5% Voting Control of ZenaTech Through Equity Grants and Asset Acquisition

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
9
Price
$2.19
Mkt Cap
$104.29M
52W Low
$1.82
52W High
$7.109
Market data snapshot near publication time

summarizeSummary

ZenaTech CEO Dr. Shaun Passley has consolidated 86.5% of the company's voting power through equity grants and an asset acquisition, following shareholder approval in January 2026.


check_boxKey Events

  • CEO Consolidates Voting Control

    Dr. Shaun Passley, CEO of ZenaTech, Inc., now controls 86.5% of the company's total voting power, significantly centralizing corporate governance.

  • Control Achieved Through Equity Grants and Asset Acquisition

    The consolidated control stems from equity grants to Dr. Passley under a new CEO employment agreement and shares issued for the acquisition of assets from Epazz, Inc., both approved by shareholders on January 30, 2026.

  • Complex Ownership Structure Detailed

    Dr. Passley's control is exercised through direct holdings, as well as through Epazz Inc. (66.4% voting power) and Ameritek Ventures, Inc. (2.5% voting power), both of which he controls.

  • Super-Voting and Convertible Shares Utilized

    The voting power includes preferred shares convertible into common shares at a 3:1 ratio and super-voting shares, each carrying 1,000 votes, contributing to the high concentration of control.


auto_awesomeAnalysis

This Schedule 13D/A filing reveals a significant consolidation of voting power by CEO Dr. Shaun Passley, who now controls 86.5% of ZenaTech, Inc.'s total votes. This substantial level of control, achieved through a combination of direct holdings, convertible preferred shares, and super-voting shares, centralizes decision-making authority. While the underlying share issuances were approved by shareholders in January 2026, this amendment provides critical detail on the extent and mechanisms of the CEO's influence. Investors should note the implications for corporate governance, as Dr. Passley's near-absolute control means he can largely dictate the company's strategic direction and major corporate actions. This filing provides important context for understanding the company's leadership structure.

At the time of this filing, ZENA was trading at $2.19 on NASDAQ in the Technology sector, with a market capitalization of approximately $104.3M. The 52-week trading range was $1.82 to $7.11. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ZENA - Latest Insights

ZENA
Apr 29, 2026, 10:15 AM EDT
Source: FinanceWire
Importance Score:
8
ZENA
Apr 29, 2026, 8:12 AM EDT
Filing Type: 20-F
Importance Score:
8
ZENA
Apr 21, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
ZENA
Apr 14, 2026, 8:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
ZENA
Apr 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
ZENA
Apr 02, 2026, 3:33 PM EDT
Filing Type: 6-K
Importance Score:
7
ZENA
Apr 02, 2026, 12:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
ZENA
Apr 02, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
ZENA
Mar 12, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
ZENA
Mar 11, 2026, 12:10 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7